echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > IBD: Clostridium difficile infection can significantly reduce the time of first bowel removal in children with Crohn's disease.

    IBD: Clostridium difficile infection can significantly reduce the time of first bowel removal in children with Crohn's disease.

    • Last Update: 2020-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Background C. difficile infection and fixation are common in pediatric Crohn's disease (CD), and the bacteria and its incurability to cure, the purpose of this study is to detect the relationship between Clostridium difficile positive and bowel resection surgery in children, and to try to find the characteristics of Clostridium difficile carriers and surgically related microbiomes.
    method researchers designed a retrospective single-center study that analyzed the association between C. difficile testing and enterosection surgery in 75 CD-child patients.
    the microbiome variants of Clostridium difficile carrying or surgical history stratified were tested on patients with fecal clostridium and fecal samples using gun gun-gun macro genome sequencing. the proportion of enterothetic surgery in patients without C. difficile was 21%
    and 67% in patients with C. difficile (P - 0.003).
    According to kaplan-Meier survival model, the risk ratio for patients who tested positive for Clostridium difficile in the first year of diagnosis was 4.4 (95% CI, 1.2-16.2; P - 0.00). this association is confirmed by the
    multivariate logistic regression analysis (OR16.2; 95% CI is 2.2-120; P is 0.006).
    in patients who underwent surgery, the difference in microbial richness and metabolic pathways observed was greater than that of Clostridium difficile carriers.
    the first year of diagnosis, the positive test for Clostridium difficile was associated with a decrease in the time of the first bowel resection surgery in pediatric Crohn's disease.
    difficult to identify the biosynthetic consumption of myothemygin carried by patients may increase the risk of surgery.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.